Kolon Life Science Inc. (KOSDAQ:102940)

South Korea flag South Korea · Delayed Price · Currency is KRW
51,300
-2,300 (-4.29%)
May 20, 2026, 3:30 PM KST
Market Cap671.55B +88.7%
Revenue (ttm)208.98B +29.5%
Net Income24.96B
EPS1,824.00
Shares Out13.09M
PE Ratio28.13
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,399
Average Volume45,343
Open53,500
Previous Close53,600
Day's Range50,200 - 53,500
52-Week Range23,750 - 72,700
Betan/a
RSI35.20
Earnings DateApr 3, 2026

About Kolon Life Science

KOLON LIFE SCIENCE, Inc. engages in the manufacture and sale of pharmaceuticals and environmental materials. It operates through the Chemical and Bio business divisions. The Chemical business division refers to pharmaceutical business and specialty chemicals business. The Bio business division relates to biopharmaceutical contract development and production services. The company was founded on April 21, 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry Chemicals
Sector Materials
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 102940
Full Company Profile

Financial Performance

Financial Statements